Introducing: The Landmark Series Kelly M. McMasters Health Services Research and Global Oncology 11 October 2019 Pages: 1 - 2
The Landmark Series: Randomized Trials Examining Surgical Margins for Cutaneous Melanoma C. V. AngelesS. L. WongG. Karakousis Melanoma 27 September 2019 Pages: 3 - 12
ASO Author Reflections: Surgical Margins for Melanoma—What’s Next? C. V. AngelesS. L. WongG. Karakousis ASO Author Reflections 25 October 2019 Pages: 13 - 14
The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes) Danielle M. BelloMark B. Faries Melanoma 18 September 2019 Pages: 15 - 21
The Landmark Series: Non-melanoma Skin Cancers Ann Y. LeeRussell S. Berman Melanoma 23 September 2019 Pages: 22 - 27
The Sunbelt Melanoma Trial Michael E. EggerCharles R. ScogginsKelly M. McMasters Melanoma 16 September 2019 Pages: 28 - 34
The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma Georgia M. BeasleyJonathan S. ZagerJohn F. Thompson Melanoma 30 August 2019 Pages: 35 - 42
Prioritizing the Patient Perspective in Oncologic Surgery Nikhil PandaAlex B. Haynes Health Services Research and Global Oncology 26 August 2019 Pages: 43 - 44
Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores Joseph D. PhillipsSandra L. Wong Health Services Research and Global Oncology 28 August 2019 Pages: 45 - 53
ASO Author Reflections: Using Patient-Reported Outcomes to Optimize Care of the Surgical Oncology Patient Joseph D. PhillipsSandra L. Wong ASO Author Reflections 23 September 2019 Pages: 54 - 55
Patient-Reported Outcomes: Understanding Surgical Efficacy and Quality from the Patient’s Perspective Jessica I. BilligErika D. SearsJennifer F. Waljee Health Services Research and Global Oncology 05 September 2019 Pages: 56 - 64
Translation of Patient-Reported Outcomes in Oncology Clinical Trials to Everyday Practice Srinivas Joga IvaturyHannah W. Hazard-JenkinsDeborah Schrag Translational Research and Biomarkers 26 August 2019 Pages: 65 - 72
Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies M. Haroon ChoudryDavid L. BartlettKiran K. Turaga Peritoneal Surface Malignancy 23 October 2019 Pages: 73 - 75
Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors Marian KhaliliHao ZhouWilbur B. Bowne Peritoneal Surface Malignancy 11 June 2019 Pages: 76 - 84
Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review Andrew SteinErin StrongHarveshp Mogal Gastrointestinal Oncology 03 October 2019 Pages: 85 - 97
Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS) Dario BarattiShigeki KusamuraMarcello Deraco Peritoneal Surface Malignancy 05 November 2019 Pages: 98 - 106
Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection Laura M. EnomotoM. Haroon ChoudryPerry Shen Peritoneal Surface Malignancy 31 July 2019 Pages: 107 - 114
ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC Laura M. EnomotoPerry Shen ASO Author Reflections 12 November 2019 Pages: 115 - 116
Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma Yasmin M. AliJoseph SweeneyEdward A. Levine Peritoneal Surface Malignancy 08 May 2019 Pages: 117 - 123
Impairments in Bowel Function, Social Function and Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Zubair BayatEmily L. TaylorAnand Govindarajan Peritoneal Surface Malignancy 09 May 2019 Pages: 124 - 131
ASO Author Reflections: The Effect of Bowel Resection During Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy on Bowel-Related Quality of Life Zubair BayatAnand Govindarajan ASO Author Reflections 10 October 2019 Pages: 132 - 133
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative Adriana C. GamboaMohammad Y. ZaidiShishir K. Maithel Peritoneal Surface Malignancy 26 June 2019 Pages: 134 - 146
Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience Daniel SolomonEliahu BekhorUmut Sarpel Gastrointestinal Oncology 05 August 2019 Pages: 147 - 153
ASO Author Reflections: Recurrence Patterns After Surgical Treatment of Pseudomyxoma Peritonei From Low-Grade Appendiceal Mucinous Neoplasms Daniel SolomonUmut Sarpel ASO Author Reflections 28 October 2019 Pages: 154 - 155
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative Mohammad Y. ZaidiRachel M. LeeCharles A. Staley III Peritoneal Surface Malignancy 10 October 2019 Pages: 156 - 164
Preoperative Radiographic Assessment Predicts Incomplete Cytoreduction in Patients with Low Grade Mucinous Adenocarcinoma of the Appendix Arvind SabesanSeth FelderSean P. Dineen Peritoneal Surface Malignancy 06 August 2019 Pages: 165 - 170
Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Zachary E. StilesAndrew J. MurphyJeremiah L. Deneve Peritoneal Surface Malignancy 08 April 2019 Pages: 171 - 178
Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Katherin Zambrano-VeraArmando SardiVadim Gushchin Peritoneal Surface Malignancy 23 October 2019 Pages: 179 - 187
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases Raja R. NarayanJennifer W. HarrisMichael I. D’Angelica Hepatobiliary Tumors 15 October 2019 Pages: 188 - 195
Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes John T. MiuraLesly A. DossettJonathan S. Zager Melanoma 04 April 2019 Pages: 196 - 202
ASO Author Reflections: Robotic Pelvic Lymph Node Dissection for Metastatic Melanoma—A Minimally Invasive Approach to a Difficult Problem John T. MiuraJonathan S. Zager ASO Author Reflections 08 July 2019 Pages: 203 - 204
50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience Allison S. Letica-KriegelJoshua C. LeinwandMichael D. Kluger Peritoneal Surface Malignancy 07 May 2019 Pages: 205 - 213
Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States Ryan J. EllisCary Jo R. SchlickRyan P. Merkow Peritoneal Surface Malignancy 11 June 2019 Pages: 214 - 221
Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery Natasha L. LeighDaniel SolomonDaniel M. Labow Peritoneal Surface Malignancy 20 June 2019 Pages: 222 - 231
Elevated Maximum Core Body Temperature During Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is Associated with Increased Postoperative Complications Ryan J. HendrixJonathan P. KassiraLaura A. Lambert Peritoneal Surface Malignancy 08 July 2019 Pages: 232 - 239
Gastric Cancer Peritoneal Carcinomatosis Risk Score Liang JiMatthew J. SelleckMaheswari Senthil Peritoneal Surface Malignancy Open access 25 July 2019 Pages: 240 - 247
ASO Author Reflections: Using the Gastric Cancer Peritoneal Carcinomatosis Risk Score to Inform Surveillance and Treatment Matthew SelleckMehaswari Senthil ASO Author Reflections 28 October 2019 Pages: 248 - 249
Diaphragmatic Peritoneal Stripping Versus Full-Thickness Resection in CRS/HIPEC: Is There a Difference? Brianne J. SullivanEliahu Y. BekhorBenjamin J. Golas Peritoneal Surface Malignancy 09 September 2019 Pages: 250 - 258
Crohn’s-Like Lymphoid Reaction is Associated with Oncological Prognosis and Nutritional Status in Patients with Pathological Stage II/III Gastric Cancer Yusuke OmuraYuji ToiyamaMasato Kusunoki Peritoneal Surface Malignancy 14 August 2019 Pages: 259 - 267
Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset Yuki ItoMitsuro KandaYasuhiro Kodera Peritoneal Surface Malignancy 06 September 2019 Pages: 268 - 275
Shorter Survival of Patients with Upper-Third Gastric Cancer Preoperatively Diagnosed as Stage IA Compared with Those with Middle to Lower Lesions Tatsuo MatsudaManabu OhashiNaoki Hiki Peritoneal Surface Malignancy 09 September 2019 Pages: 276 - 283
Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study Toshifumi YamaguchiAtsuo TakashimaNarikazu Boku Peritoneal Surface Malignancy 18 September 2019 Pages: 284 - 292
Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC Wilhelm GrafPeter H. CashinHelgi Birgisson Peritoneal Surface Malignancy Open access 30 September 2019 Pages: 293 - 300
ASO Author Reflections: Can Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy be Improved? Wilhelm GrafHelgi Birgisson ASO Author Reflections Open access 13 September 2019 Pages: 301 - 302
Implementation of an Enhanced Recovery After Surgery (ERAS) Program is Associated with Improved Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Christopher WebbRyan DayNabil Wasif Peritoneal Surface Malignancy 11 October 2019 Pages: 303 - 312
Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer Hayemin LeeHan Hong LeeJunhyun Lee Peritoneal Surface Malignancy 22 October 2019 Pages: 313 - 320
